Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Published Online
on July 19, 2007

Arteriosclerosis, Thrombosis, and Vascular Biology. 2007
Published online before print July 19, 2007, doi: 10.1161/ATVBAHA.107.149278
A more recent version of this article appeared on September 1, 2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
27/9/1955    most recent
ATVBAHA.107.149278v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dragoni, S.
Right arrow Articles by Parker, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dragoni, S.
Right arrow Articles by Parker, J. D.

Submitted on June 4, 2007
Accepted on June 28, 2007

Pentaerythrityl Tetranitrate and Nitroglycerin, but not Isosorbide Mononitrate, Prevent Endothelial Dysfunction Induced by Ischemia and Reperfusion

Saverio Dragoni ; Tommaso Gori ; Monica Lisi ; Giuseppe Di Stolfo ; Andrea Pautz ; Hartmut Kleinert ; and John D. Parker *

From the Department of Internal, Cardiovascular, and Geriatric Medicine (S.D., M.L., G.D.S., T.G.), Azienda Ospedaliera Universitaria Senese, University of Siena, Italy; the Division of Cardiology (J.D.P., T.G.), Mount Sinai and University Health Network Hospitals, Toronto, Canada; and the Department of Pharmacology (A.P., H.K.), Johannes Gutenberg University, Mainz, Germany.

* To whom correspondence should be addressed. E-mail: jdp{at}ca.inter.net.

Background--Short term exposure to nitroglycerin (GTN) has protective properties that are similar to ischemic preconditioning. Whether other organic nitrates such as pentaerithrityl tetranitrate (PETN) and isosorbide mononitrate (ISMN) have similar protective effects has not been explored.

Methods and Results--In a randomized, parallel, double blind, controlled trial, 37 healthy young volunteers received no therapy (n=10), transdermal GTN 1.2 mg for 2 hours (n=9), PETN 80 mg (n=9), or ISMN 40 mg (n=9). Twenty-four hours later, endothelium-dependent flow-mediated vasodilation (FMD) was measured before and after local exposure to ischemia and reperfusion (IR). In the no therapy group, IR blunted FMD (FMD after IR: 1.9±0.6%, P<0.05), an effect that was prevented by GTN (FMD after IR: 5.3±1.4%, P<0.05 compared with no therapy). PETN had the same protective effect (FMD after IR: 8.1±1.3%, P<0.05 compared with no therapy), whereas ISMN had no significant pharmacological preconditioning effect (FMD after-IR: 3.6±0.8%, P=ns compared with no therapy). Vitamin C (n=8) did not modify PETN preconditioning (FMD after IR: 6.3±0.9%, P=ns compared with before IR), showing that this phenomenon is not mediated by oxygen free radical production. In an effort to identify the mechanism of PETN preconditioning, isolated human endothelial cells were incubated with PETN, GTN, or ISMN. Only PETN induced expression of the genes encoding for heme oxygenase and ferritin, which have been involved in ischemic and pharmacological preconditioning.

Conclusions--We show important differences among organic nitrates in their capacity to prevent IR-induced endothelial dysfunction. GTN and PETN, but not ISMN, have this preconditioning effect. The potential clinical implications of these data warrant further investigation.


Key words: organic nitrates • nitric oxide • preconditioning • oxygen-derived free radicals • ischemia reperfusion injury




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
T. Gori and J. D. Parker
Nitrate-Induced Toxicity and Preconditioning: A Rationale for Reconsidering the Use of These Drugs
J. Am. Coll. Cardiol., July 22, 2008; 52(4): 251 - 254.
[Abstract] [Full Text] [PDF]